In this episode, we’ll focus on 2 new clinically relevant drug approvals impacting both community and hospital pharmacists – suzetrigine and aztreonam-avibactam. We’ll discuss efficacy data which led to their approval, potential adverse effects and counseling points for pharmacists to be aware of.

Each month, APhA will release two, 10 to 15 minute podcast episodes offering a fresh dose of education highlights, practice pearls, and insights to inform your pharmacy practice and advance patient care.  Listen to new episodes at your convenience! Both members and nonmembers can log into their APhA Learning Library account to successfully complete a short assessment at the end of each month to earn 0.5 hours of CE credits (.05 CEU). 

Tune in now on our website or subscribe via YouTube, Spotify, or Apple Podcasts.

Disclaimer: The content is intended for informational purposes only and should not be considered or taken as medical advice. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of any entities they represent or its employees.